Significance of albumin and C-reactive protein variations in 300 end stage renal disease patients in Tehran University of Medical Sciences hospitals during year 2010

Acta Medica Iranica

Volumn 50, Issue 3, 2012, Pages 197-202

  Dashti, Nasrin ^a   Einollahi, Nahid ^a   Nabatchian, Fariba ^a   Sarabi, Mostafa Moradi ^b   Zarebavani, Mitra ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CRP; CVD; ESRD; Hypoalbuminemia

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NUTRITIONAL ASSESSMENT; PROTEIN BLOOD LEVEL; TREATMENT DURATION;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; HYPOALBUMINEMIA; INFLAMMATION; INFLAMMATION MEDIATORS; IRAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN-ENERGY MALNUTRITION; RENAL DIALYSIS; SERUM ALBUMIN; TIME FACTORS;

EID: 84858768292     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Shaheen FAM, AL-Khader AA. Epidemiology and causes of End stage Renal Disease (ESRD). Saudi J Kidney Dis Transplant 2005;16(3):277-81.
2. Kopple JD, Greene T, Chumlea WC, Hollinger D, Maroni BJ, Merrill D, Scherch LK, Schulman G, Wang SR, Zimmer GS. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int 2000;57(4):1688-703.
3. Qureshi AR, Alvestrand A, Danielsson A, Divino-Filho JC, Gutierrez A, Lindholm B, Bergström J. Factors predicting malnutrition in hemodialysis patients: a crosssectional study. Kidney Int 1998;53(3):773-82.
4. Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999;55(5):1899-911.
5. Stenvinkel P, Barany P, Chung SH, Lindholm B, Heimbürger O. A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients. Nephrol Dial Transplant 2002;17(7):1266-74.
6. Avram MM, Goldwasser P, Erroa M, Fein PA. Predictors of survival in continuous ambulatory peritoneal dialysis patients: the importance of prealbumin and other nutritional and metabolic markers. Am J Kidney Dis 1994;23(1):91-8.
7. Jansen MA, Korevaar JC, Dekker FW, Jager KJ, Boeschoten EW, Krediet RT; NECOSAD Study Group. Renal function and nutritional status at the start of chronic dialysis treatment. J Am Soc Nephrol 2001;12(1):157-63.
8. Caimi G, Carollo C, Lo Presti R. Pathophysiological and clinical aspects of malnutrition in chronic renal failure. Nutr Res Rev 2005;18(1):89-97.
9. Kaysen GA. Biological basis of hypoalbuminemia in ESRD. J Am Soc Nephrol 1998;9(12):2368-76.
10. Heimburger O, Bergstrom J, Lindholm B. Is serum albumin an indicator of nutritional status in CAPD patients? Perit Dial Intl 1994;14:108-14.
11. Jones CH, Newstead CG, Will EJ, Smye SW, Davison AM. Assessment of nutritional status in CAPD patients: serum albumin is not a useful measure. Nephrol Dial Transplant 1997;12(7):1406-13.
12. Heimbürger O, Qureshi AR, Blaner WS, Berglund L, Stenvinkel P. Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. Am J Kidney Dis 2000;36(6):1213-25.
13. Stenvinkel P, Alvestrand A. Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial 2002;15(5):329-37.
14. Mitch WE. Malnutrition: a frequent misdiagnosis for hemodialysis patients. J Clin Invest 2002;110(4):437-9.
15. Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 2001;59(2):407-14.
16. Razeghi E, Omati H, Maziar S, Khashayar P, Mahdavi-Mazdeh M. Chronic inflammation increases risk in hemodialysis patients. Saudi J Kidney Dis Transpl 2008;19(5):785-9.
17. Grootendorst DC, de Jager DJ, Brandenburg VM, Boeschoten EW, Krediet RT, Dekker FW; NECOSAD Study Group. Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients--no additional power for mortality prediction with high-sensitivity CRP. Nephrol Dial Transplant 2007;22(11):3277-84.
18. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, Heimovitz H, Cohen HJ, Wallace R. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999;106(5):506-12.
19. Menon V, Greene T, Wang X, Pereira AA, Marcovina SM, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ. Creactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 2005;68(2):766-72.
20. Bensen JT, Langefeld CD, Li L, McCall CE, Cousart SL, Dryman BN, Freedman BI, Bowden DW. Association of an IL-1A 3'UTR polymorphism with end-stage renal disease and IL-1 alpha expression. Kidney Int 2003;63(4):1211-9.
21. Kaysen GA. Interpretation of plasma protein measurements in end-stage renal disease. Blood Purif 2000;18(4):337-42.
22. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15(5):458-82.
23. Steinman TI. Serum albumin: its significance in patients with ESRD. Semin Dial 2000;13(6):404-8.
24. Wang AY, Sea MM, Ho ZS, Lui SF, Li PK, Woo J. Evaluation of handgrip strength as a nutritional marker and prognostic indicator in peritoneal dialysis patients. Am J Clin Nutr 2005;81(1):79-86.
25. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55(2):648-58.
26. Helal I, Smaoui W, Hamida FB, Ouniss M, Aderrahim E, Hedri H, Elyounsi F, Maiz HB, Abdallah TB, Kheder A. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients. Saudi J Kidney Dis Transpl 2010;21(1):59-62.
27. Kato A, Takita T, Furuhashi M, Maruyama Y, Hishida A. Comparison of serum albumin, C-reactive protein and carotid atherosclerosis as predictors of 10-year mortality in hemodialysis patients. Hemodial Int 2010;14(2):226-32.
28. Fellah H, Hammami MB, Feki M, Boubaker K, Abdallah TB, Lacour B, Mebazaa A, Kaabachi N. Predictors for cardiovascular morbidity and overall mortality in Tunisian ESRD patients: a six year prospective study. Clin Biochem 2009;42(7-8):648-53.
29. Pecoits-Filho R, Bárány P, Lindholm B, Heimbürger O, Stenvinkel P. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 2002;17(9):1684-8.
30. Honda H, Qureshi AR, Heimbürger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006;47(1):139-48.
31. Mak RH, Cheung WW. Is ghrelin a biomarker for mortality in end-stage renal disease? Kidney Int 2011;79(7):697-9.
32. Dashti N, Einollahi N, Nabatchian F. Leptin and Interleukin-6 in End-Stage Renal Disease. Pak J Med Sci 2008;24(5):694-97.